论文部分内容阅读
米非司酮(ＲＵ486)作为第一个用于临床的孕激素(Ｐｒｏｇｅｓｔｅｒｏｎｅ,Ｐ)和糖皮质激素(Ｇｌｕｃｏｃｏｒｔｉｃｏｓｔｅｒｏｉｄ,Ｇ)拮抗剂,其广泛的生理作用引起国内外学者的普遍重视,随着研究的不断深入,近年来关于其在临床不同领域应用的报道也越来越多,现综述如下:1
As the first clinical trial of Progesterone (P) and Glucocorticosteroid (G), mifepristone (RU486) has attracted a great deal of attention from scholars both at home and abroad because of its broad physiological role. In recent years, more and more reports on its application in different clinical fields are summarized as follows: 1